Nomura Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
Nomura Asset Management's AZN Position: Q1 2026 in Review
Nomura Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 11,645 shares — an estimated $2.25M sold.
Nomura Asset Management first reported a position in AZN in Q1 2022 and held it in 16 quarters. The position peaked at $7.06M in Q2 2024. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Nomura Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Nomura Asset Management sold 11,645 AstraZeneca shares in Q1 2026, an estimated $2.25M.
- Nomura Asset Management first reported a position in AstraZeneca in Q1 2022 and held it in 16 quarters.
- Nomura Asset Management's AstraZeneca position peaked at $7.06M in Q2 2024.
- 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Nomura Asset Management's 13F filing for Q1 2026, filed 11 May 2026.